Edwards Lifesciences Corp logo

Edwards Lifesciences Corp

NEW
WBO:EWLS (USA)   Ordinary Shares
€ 80.56 +0.84 (+1.05%) Jun 26
48.03
P/B:
5.07
Market Cap:
€ 46.01B ($ 53.26B)
Enterprise V:
€ 43.40B ($ 50.24B)
Volume:
0
Avg Vol (2M):
129.00
Trade In:

Business Description

Edwards Lifesciences Corp logo
Edwards Lifesciences Corp
NAICS : 339113 SIC : 3842
ISIN : US28176E1082

Share Class Description:

WBO:EWLS: Ordinary Shares

Total Employee Number:

16,000
Description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Name Current Vs Industry Vs History
Cash-To-Debt
5.22
Equity-to-Asset
0.78
Debt-to-Equity
0.07
Debt-to-EBITDA
0.45
Interest Coverage
85.34
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
13.25
Distress
Grey
Safe
Beneish M-Score
-2.1
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
84.32
9-Day RSI
75.87
14-Day RSI
70.44
3-1 Month Momentum %
3.78
6-1 Month Momentum %
2.12
12-1 Month Momentum %
12.82

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
4.42
Quick Ratio
3.63
Cash Ratio
2.61
Days Inventory
295.19
Days Sales Outstanding
40.47
Days Payable
47.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
1.5
Shareholder Yield %
2.01

Edwards Lifesciences Corp Filings

Filing Date Document Date Form
No Filing Data

Edwards Lifesciences Corp Stock Events

Financials Calendars
Event Date Price (€)
Third quarter earnings conference call for 2026 2026-10-30 17:00 In 125 days
Third quarter earnings results for 2026 2026-10-30 In 124 days
Second quarter earnings conference call for 2026 2026-07-24 17:00 In 27 days
Second quarter earnings results for 2026 2026-07-24 In 26 days
Guidance call for 2026 2026-05-12 15:40 65.18 (-3.98%)
General meeting for 2026 2026-05-07 10:00 70.52 (-0.40%)
First quarter earnings conference call for 2026 2026-04-23 17:00 69.14 (+1.29%)
First quarter earnings results for 2026 2026-04-23 69.14 (+1.29%)
Leerink Global Healthcare Conference 2026-03-11 10:00 73.32 (+0.78%)
Barclays 28th Annual Global Healthcare Conference 2026-03-10 10:00 72.07 (+3.97%)
Show
Entries

Articles on Edwards Lifesciences Corp

No articles.